Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma

Journal of Surgical Oncology

Volumn 97, Issue 6, 2008, Pages 544-550

  Lin, Chiao Ying ^a,b   Jeng, Yung Ming ^a   Chou, Han Yi ^a   Hsu, Hey Chi ^a   Yuan, Ray Hwang ^b   Chiang, Chun Pin ^a,b   Kuo, Mark Yen Ping ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Annexin A1; Oral squamous cell carcinoma; Prognosis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; LIPOCORTIN 1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING;

EID: 43049149777     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20992     Document Type: Article

References (32)

1. 1 Moore SR, Johnson NW, Pierce AM, et al.: The epidemiology of mouth cancer: A review of global incidence. Oral Dis 2000 ; 6: 65–74.
2. 2 Vokes EE, Weichselbaum RR, Lippman SM, et al.: Head and neck cancer. N Engl J Med 1993 ; 328: 184–194.
3. 3 Johnstone SA, Hubaishy I, Waisman DM: Regulation of annexin I‐dependent aggregation of phospholipid vesicles by protein kinase C. Biochem J 1993 ; 294: 801–807.
4. 4 Moss SE, Morgan RO: The annexins. Genome Biol 2004 ; 5: 219.
5. 5 Gerke V, Moss SE: Annexins: From structure to function. Physiol Rev 2002 ; 82: 331–371.
6. 6 Alldridge LC, Bryant CE: Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 2003 ; 290: 93–107.
7. 7 Davidson FF, Dennis EA: Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2. Biochem Pharmacol 1989 ; 38: 3645–3651.
8. 8 Huo XF, Zhang JW: Annexin1 regulates the erythroid differentiation through ERK signaling pathway. Biochem Biophys Res Commun 2005 ; 331: 1346–1352.
9. 9 Garcia Pedrero JM, Fernandez MP, Morgan RO, et al.: Annexin A1 down‐regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004 ; 164: 73–79.
10. 10 Skouteris GG, Schroder CH: The hepatocyte growth factor receptor kinase‐mediated phosphorylation of lipocortin‐1 transduces the proliferating signal of the hepatocyte growth factor. J Biol Chem 1996 ; 271: 27266–27273.
11. 11 Pencil SD, Toth M: Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma. Clin Exp Metastasis 1998 ; 16: 113–121.
12. 12 Masaki T, Tokuda M, Ohnishi M, et al.: Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996 ; 24: 72–81.
13. 13 Bai XF, Ni XG, Zhao P, et al.: Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004 ; 10: 1466–1470.
14. 14 Wang KL, Wu TT, Resetkova E, et al.: Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: Association with poor outcome. Clin Cancer Res 2006 ; 12: 4598–4604.
15. 15 Johnson MD, Kamso‐Pratt J, Pepinsky RB, et al.: Lipocortin‐1 immunoreactivity in central and peripheral nervous system glial tumors. Hum Pathol 1989 ; 20: 772–776.
16. 16 Paweletz CP, Ornstein DK, Roth MJ, et al.: Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000 ; 60: 6293–6297.
17. 17 Liu Y, Wang HX, Lu N, et al.: Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma. World J Gastroenterol 2003 ; 9: 645–649.
18. 18 Hippo Y, Yashiro M, Ishii M, et al.: Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001 ; 61: 889–895.
19. 19 Rodrigo JP, Garcia‐Pedrero JM, Fernandez MP, et al.: Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am J Rhinol 2005 ; 19: 483–487.
20. 20 Silistino‐Souza R, Rodrigues‐Lisoni FC, Cury PM, et al.: Annexin 1: Differential expression in tumor and mast cells in human larynx cancer. Int J Cancer 2007 ; 120: 2582–2589.
21. 21 Kang JS, Calvo BF, Maygarden SJ, et al.: Dysregulation of annexin I protein expression in high‐grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 2002 ; 8: 117–123.
22. 22 Radke S, Austermann J, Russo‐Marie F, et al.: Specific association of annexin 1 with plasma membrane‐resident and internalized EGF receptors mediated through the protein core domain. FEBS Lett 2004 ; 578: 95–98.
23. 23 Kim YS, Ko J, Kim IS, et al.: PKCdelta‐dependent cleavage and nuclear translocation of annexin A1 by phorbol 12‐myristate 13‐acetate. Eur J Biochem 2003 ; 270: 4089–4094.
24. 24 Pathology and genetics of head and neck tumors. Lyon, France: IARCPress ; 2005.
25. 25 Lin CY, Hung HC, Kuo RC, et al.: Survivin expression predicts poorer prognosis in patients with areca quid chewing‐related oral squamous cell carcinoma in Taiwan. Oral Oncol 2005 ; 41: 645–654.
26. 26 Chen YS, Wang JT, Chang YF, et al.: Expression of hepatocyte growth factor and c‐met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 2004 ; 33: 209–217.
27. 27 Fassetta M, D'Alessandro L, Coltella N, et al.: Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK‐mediated apoptosis. Cell Signal 2006 ; 18: 1967–1976.
28. 28 Novak A, Dedhar S: Signaling through beta‐catenin and Lef/Tcf. Cell Mol Life Sci 1999 ; 56: 523–537.
29. 29 Ma AS, Ozers LJ: Annexins I and II show differences in subcellular localization and differentiation‐related changes in human epidermal keratinocytes. Arch Dermatol Res 1996 ; 288: 596–603.
30. 30 Rhee HJ, Kim GY, Huh JW, et al.: Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl‐reactive agent. Eur J Biochem 2000 ; 267: 3220–3225.
31. 31 Grau JJ, Domingo J, Blanch JL, et al.: Multidisciplinary approach in advanced cancer of the oral cavity: Outcome with neoadjuvant chemotherapy according to intention‐to‐treat local therapy. A phase II study. Oncology 2002 ; 63: 338–345.
32. 32 Xia W, Lau YK, Zhang HZ, et al.: Combination of EGFR, HER‐2/neu, and HER‐3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 1999 ; 5: 4164–4174.